Abstract 4568: The One Health Consortium and combination immunotherapy: evaluating M032, a genetically engineered HSV-1 expressing Il-12, in combination with a checkpoint inhibitor in canine glioma patients

Authors: M. R. Chambers, R. T. Bentley, David Crossman, Jeremy B. Foote, J. W. Koehler, James M. Markert, Simon R. Platt, Nidal B. Omar, D. M. Self, Andy Shores, Don Sorjonen, Alicia M. Waters, Amy B. Yanke, G Y. Gillespie

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-4568

Source: Full article